Key result
Dipicolinic acid reduces cytolytic markers and oxidative stress in rats with diclofenac-induced myocardial injury.
Why the study?
To evaluate the cardioprotective potential of dipicolinic acid and its effect on oxidative status and the functioning of superoxide dismutase, catalase, and heat shock proteins in diclofenac-induced myocardial injury.
Does dipicolinic acid improve oxidative status and antioxidant enzyme activity in a rat model of diclofenac-induced myocardial injury?
RCT
Randomly assigned
Does dipicolinic acid improve oxidative status and antioxidant enzyme activity in a rat model of diclofenac-induced myocardial injury?
Dipicolinic acid demonstrates cardioprotective effects in a rat model of diclofenac-induced myocardial injury by reducing oxidative stress and normalizing antioxidant and heat shock protein expression.
Answers are grounded in this paper and cite their sources.
DPA may protect rat hearts from diclofenac injury; leaves open any human cardioprotective role pending clinical data.
The aim of the study was to evaluate the cardioprotective potential of dipicolinic acid (DPA) and its effect on oxidative status and the functioning of superoxide dismutase, catalase and heat shock proteins in a model of diclofenac-induced myocardial injury. Rats were randomly assigned to four groups: control group; animals with diclofenac-induced myocardial injury; rats with pathology received intragastric injections of DPA at a dosage of 10 mg/kg; rats with pathology received DPA at a dosage of 20 mg/kg. The results of the study showed that the administration of DPA to rats with myocardial damage induced by diclofenac led to a significant decrease in the activity of cardiomyocyte cytolytic marker enzymes. Additionally, the tested compound significantly decreased the parameters of bio-chemiluminescence, which reflect the intensity of free radical-induced oxidation. DPA restored the activity of aconitate hydratase, prevented citrate accumulation, and changed superoxide dismutase and catalase activity, and their genes mRNA levels toward control values. At the same time, the administration of DPA resulted in a normalization in total chaperone activity and the expression of mRNA of heat shock proteins. DPA injections also contributed to the normalization of mRNA levels for nuclear factor erythroid 2-associated factor 2 and hypoxia-inducible factor. The observed positive changes may be attributed to an improvement in myocardial metabolic processes as a result of DPA action, which may have antithrombotic effects and inhibit the activity of free radical-mediated oxidation of biological molecules.
No takes yet. Share an insight, caveat, or question.
Kryl’skii et al. (2026) conducted an RCT in Diclofenac-induced myocardial injury. Dipicolinic acid (DPA) vs. Control group and untreated diclofenac-induced myocardial injury group was evaluated on Activity of cardiomyocyte cytolytic marker enzymes, bio-chemiluminescence parameters, and antioxidant enzyme activity. Dipicolinic acid administration in rats with diclofenac-induced myocardial injury significantly decreased cytolytic marker enzymes and free radical-induced oxidation, and restored antioxidant enzymes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: